• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCandel Therapeutics
    Picture of Candel Therapeutics logo

    CADL — Candel Therapeutics News Story

    $9.790.000.00%
    us flag iconLast trade - 00:00
    HealthcareMid CapMomentum Trap
    • Market Cap
      $717.32m
    • Enterprise Value
      $569.96m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CADL Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CADL Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM

    Picture of Candel Therapeutics logoCandel Therapeutics
    02/06/2022 14:32
    NASDAQ TRADE HALT  CADL.O  VOLATILITY TRADING PAUSE AT 09:31 AM
    

    Recent news on Candel Therapeutics

    See all news
    • Brief: Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints In Patients From Phase 3 Trial Of Aglatimagene Besadenovec (Can-2409)

      15/05/2026 21:22
    • Candel Therapeutics reports Q1 loss

      14/05/2026 13:15
    • Brief: Candel Therapeutics Q1 Net Income USD -8.861 Million

      14/05/2026 13:05
    • Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

      02/04/2026 22:43
    • Brief: Candel Therapeutics Inc Extended Survival Tail Observed In Trial Of Aglatimagene Besadenovec

      17/03/2026 12:14

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.